Survival advantage of kidney transplantation over dialysis in patients with hepatitis C: A systematic review and meta-analysis

Transplantation

Volumn 95, Issue 7, 2013, Pages 943-948

  Ingsathit, Atiporn ^a   Kamanamool, Nanticha ^a   Thakkinstian, Ammarin ^a   Sumethkul, Vasant ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Dialysis; Hepatitis C infection; Kidney transplant; Systematic review; Waiting lists

Indexed keywords

AGE; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; DIALYSIS; DISEASE COURSE; HEPATITIS C; HUMAN; INFECTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL; SYSTEMATIC REVIEW;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; FEMALE; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ODDS RATIO; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 84876281146     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182848de2     Document Type: Article

References (33)

1. Fabrizi F, Martin P, Ponticelli C. Hepatitis C virus infection and renal transplantation. Am J Kidney Dis 2001; 38: 919.
2. Tokars JI, Alter MJ, Favero MS, et al. National surveillance of dialysis associated diseases in the United States, 1992. ASAIO J 1994; 40: 1020.
3. Gane E, Pilmore H. Management of chronic viral hepatitis before and after renal transplantation. Transplantation 2002; 74: 427.
4. Goodkin DA, Bragg-Gresham JL, Koenig KG, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14: 3270.
5. Vosnides GG. Hepatitis C in renal transplantation. Kidney Int 1997; 52: 843.
6. Hanafusa T, Ichikawa Y, Kishikawa H, et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998; 66: 471.
7. Mathurin P, Mouquet C, Poynard T, et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29: 257.
8. Mahmoud IM, Elhabashi AF, Elsawy E, et al. The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study. Am J Kidney Dis 2004; 43: 131.
9. Stehman-Breen CO, Emerson S, Gretch D, et al. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998; 32: 629.
10. Pereira BJ, Natov SN, Bouthot BA, et al. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1998; 53: 1374.
11. Espinosa M, Martin-Malo A, Alvarez de Lara MA, et al. Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients. Nephrol Dial Transplant 2001; 16: 1669.
12. Fabrizi F, Martin P, Dixit V, et al. Meta-analysis: effect of hepatitis C virus infection on mortality in dialysis. Aliment Pharmacol Ther 2004; 20: 1271.
13. Fabrizi F, Martin P, Dixit V, et al. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 2005; 5: 1452.
14. Huo TI, Yang WC, Wu JC, et al. Long-term outcome of kidney transplantation in patients with hepatitis C virus infection. Hepato-gastroenterology 2001; 48: 169.
15. Knoll GA, Tankersley MR, Lee JY, et al. The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients. Am J Kidney Dis 1997; 29: 608.
16. Bloom RD, Sayer G, Fa K, et al. Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list. Am J Transplant 2005; 5: 139.
17. Sezer S, Ozdemir FN, Akcay A, et al. Renal transplantation offers a better survival in HCV-infected ESRD patients. Clin Transplant 2004; 18: 619.
18. Maluf DG, Fisher RA, King AL, et al. Hepatitis C virus infection and kidney transplantation: predictors of patient and graft survival. Transplantation 2007; 83: 853.
19. Lezaic V, Stosovic M, Marinkovic J, et al. Hepatitis B and hepatitis C virus infection and outcome of hemodialysis and kidney transplant patients. Ren Fail 2008; 30: 81.
20. Scott DR, Wong JK, Spicer TS, et al. Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand. Transplantation 2010; 90: 1165.
21. Roth D, Gaynor JJ, Reddy KR, et al. Effect of kidney transplantation on outcomes among patients with hepatitis C. J Am Soc Nephrol 2011; 22: 1152.
22. Abbott KC, Lentine KL, Bucci JR, et al. The impact of transplantation with deceased donor hepatitis C-positive kidneys on survival in waitlisted long-term dialysis patients. Am J Transplant 2004; 4: 2032.
23. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiologyofcardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112.
24. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154.
25. Fabrizi F, Messa P, Martin P, et al. Hepatitis C virus infection and post-transplant diabetes mellitus among renal transplant patients: a meta-analysis. Int J Artif Organs 2008; 31: 675.
26. Torres J, Aguado JM, San Juan R, et al. Hepatitis C virus, an important risk factor for tuberculosis in immunocompromised: experience with kidney transplantation. Transpl Int 2008; 21: 873.
27. Dominguez-Gil B, Morales JM. Transplantation in the patient with hepatitis C. Transpl Int 2009; 22: 1117.
28. Cueto-Manzano AM, Morales-Buenrostro LE, Gonzalez-Espinoza L, et al. Markers of inflammation before and after renal transplantation. Transplantation 2005; 80: 47.
29. Lopez-Gomez JM, Verde E, Perez-Garcia R. Blood pressure, left ventricular hypertrophy and long-term prognosis in hemodialysis patients. Kidney Int Suppl 1998; 68: S92.
30. Natov SN, Lau JY, Ruthazer R, et al. virus genotype does not affect patient survival among renal transplant candidates. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1999; 56: 700.
31. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl 2008; 73(Suppl 1): S53.
32. Moreno SG, Sutton AJ, Turner EH, et al. Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications. BMJ 2009; 339: b2981.
33. Nuesch E, Trelle S, Reichenbach S, et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 2010; 341: c3515.